The Motley Fool Previous Page


EU Approval? Fat Chance!

http://www.fool.com/investing/high-growth/2012/09/21/eu-approval-fat-chance.aspx

Brian Orelli, Ph.D.
September 21, 2012

In general, there's a little lower threshold for getting a drug approved by the European Medicines Agency than there is for approval by the Food and Drug Administration. Merck's (NYSE: MRK  ) Cordaptive, Cell Therapeutics' (Nasdaq: CTIC  ) Pixuvri, and InterMune's (Nasdaq: ITMN  ) Esbriet were all approved in Europe, but were -- at least initially -- rejected in the U.S.

<